Basics 89bio, Inc. Common Stock IPO Date: November 19, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.47B Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.48% Avg Daily Range (30 D): $0.27 | 3.11% Avg Daily Range (90 D): $0.34 | 4.23% Institutional Daily Volume Avg Daily Volume: .81M Avg Daily Volume (30 D): 1.97M Avg Daily Volume (90 D): 1.68M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 96 Avg Trade Size (Sh.) (90 D): 88 Institutional Trades Total Inst.Trades: 1,162 Avg Inst. Trade: $2.06M Avg Inst. Trade (30 D): $2.01M Avg Inst. Trade (90 D): $2.1M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.47M Avg Closing Trade (30 D): $2.16M Avg Closing Trade (90 D): $2.34M Avg Closing Volume: 219.86K     News Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight Nov 29, 2024 @ 6:30 PM 89bio Announces Inducement Grants Under Nasdaq Lis... Source: N/A Nov 13, 2024 @ 4:58 AM 89bio, Inc. Announces Upsized Pricing of $125.0 Mi... Source: 89Bio, Inc. Jun 14, 2024 @ 8:05 PM 89bio Announces Inducement Grants Under Nasdaq Lis... Source: 89bio, Inc. May 22, 2024 @ 8:05 PM 89bio to Present 48-Week Data from ENLIVEN Phase 2... Source: 89bio, Inc. Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.49 $-1.39 Diluted EPS $-.49 $-1.39 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -71.28M $ -149.07M Operating Income / Loss $ $ -75.91M $ -151.94M Cost of Revenue $ $ $ Net Cash Flow $ $ 189.34M $ -120.81M PE Ratio